cycloserine has been researched along with Pulsatile Tinnitus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kallogjeri, D; Krings, JG; Lenze, EJ; Nicklaus, J; Piccirillo, JF; Rodebaugh, TL; Wineland, A | 1 |
Kapolowicz, MR; Thompson, LT | 1 |
Bialik, IB | 1 |
1 trial(s) available for cycloserine and Pulsatile Tinnitus
Article | Year |
---|---|
A novel treatment for tinnitus and tinnitus-related cognitive difficulties using computer-based cognitive training and D-cycloserine.
Topics: Adult; Aged; Cognition Disorders; Cognitive Behavioral Therapy; Cycloserine; Double-Blind Method; Feasibility Studies; Female; Humans; Male; Middle Aged; Patient Compliance; Tinnitus | 2015 |
2 other study(ies) available for cycloserine and Pulsatile Tinnitus
Article | Year |
---|---|
Acute high-intensity noise induces rapid Arc protein expression but fails to rapidly change GAD expression in amygdala and hippocampus of rats: Effects of treatment with D-cycloserine.
Topics: Amygdala; Animals; Auditory Cortex; Biomarkers; Corticosterone; Cycloserine; Cytoskeletal Proteins; Disease Models, Animal; Glutamate Decarboxylase; Hearing Loss, Noise-Induced; Hippocampus; Humans; Male; Nerve Tissue Proteins; Neuronal Plasticity; Noise; Rats; Rats, Long-Evans; Tinnitus | 2016 |
[Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
Topics: Adolescent; Adult; Albuminuria; Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cycloserine; Depression, Chemical; Drug Resistance, Microbial; Eosinophilia; Ethionamide; Headache; Hearing Disorders; Hematuria; Humans; Isoniazid; Kanamycin; Lung Diseases; Middle Aged; Mycobacterium tuberculosis; Pruritus; Pyrazinamide; Respiratory Therapy; Tachycardia; Thiosemicarbazones; Time Factors; Tinnitus; Tuberculosis, Pulmonary; Vertigo; Vestibule, Labyrinth; Viomycin | 1971 |